🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07683663
Starting soon Not applicable

QIPB vs SI-FICB for Postoperative Analgesia After Total Hip Arthroplasty

NCT07683663 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-06-30
Last updated
2026-07-06

Condition(s) studied

Hip OsteoarthritisTotal Hip Arthroplasty (THA)Postoperative PainAcute Pain

Investigational drug(s) / intervention(s)

Supra-Inguinal Fascia Iliaca Compartment BlockQuadro-Iliac Plane Block

Supra-Inguinal Fascia Iliaca Compartment Block: SIFICB is an ultrasound-guided fascial plane block performed via a supra-inguinal approach to the iliac fascia compartment, targeting the femoral nerve, lateral femoral cutaneous nerve, and obturator nerve. Single-shot, US-guided, 40 mL 0.25% bupivacaine, before GA induction.

Quadro-Iliac Plane Block: QIPB is a facial plane block performed under ultrasound guidance with local anesthetic in the interfascial plane between the erector spinae and the quadratus lumborum muscle, at the distal attachment site of the quadratus lumborum muscle on the iliac crest. Single-shot, US-guided, 40 mL 0.25% bupivacaine, before GA induction.

Study summary

Total hip arthroplasty (THA) causes moderate-to-severe postoperative pain. The PROSPECT guideline recommends the supra-inguinal fascia iliaca compartment block (SI-FICB) for THA, whereas evidence for newer quadratus-lumborum-family blocks is limited. The quadro-iliac plane block (QIPB) is a recently described fascial plane block, and no study has compared QIPB with SI-FICB head-to-head in any surgical context. In this prospective, double-blind, patients undergoing elective THA who receive one of the two routinely used preoperative blocks (SI-FICB or QIPB, chosen by the attending anesthesiologist as part of routine care) are systematically observed and compared. The primary objective is to assess whether the postoperative analgesic efficacy of QIPB is non-inferior to SI-FICB, using the resting NRS pain score at 6 hours postoperatively as the primary endpoint (non-inferiority margin Δ = 1.3).

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18-75 years * Scheduled for elective primary total hip arthroplasty * ASA physical status I-III * Able to understand and communicate in Turkish and complete assessment scales * Completed preoperative anesthesia evaluation and approved for surgery * Signed written informed consent Exclusion Criteria: * Known allergy/contraindication to any local anesthetic, including bupivacaine * Coagulopathy or anticoagulant/antiplatelet therapy contraindicating block (per ASRA 2022) * Active infection or skin breakdown at the block site * Chronic opioid use (≥3 months daily) or history of opioid dependence * Morbid obesity (BMI \> 40 kg/m²) * Cognitive impairment or communication difficulty precluding reliable NRS/QoR-15 assessment * Pregnancy or breastfeeding * Revision THA or emergency THA for fracture * Intraoperative complications requiring major protocol deviation (e.g., \>1000 mL blood loss, cardiac arrest) * Technically failed block (no sensory change at any region on the T1 cold test)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Dokuz Eylül University Izmir Balçova

More Dokuz Eylul University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07683663 on ClinicalTrials.gov ↗ ← All trials in Turkey